Optometry Clinic, National Autonomous University
Mexico City, Mexico
NCT Number: NCT03578926
Prospective study to evaluate the clinical performance of fanfilcon A toric contact lens and senofilcon A toric contact lens after two weeks of wear.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Mexico City, Mexico
The aim of this prospective study is to evaluate the clinical performance of Avaira Vitality toric and ACUVUE OASYS® for ASTIGMATISM contact lenses after 2-weeks of wear in each pair.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
contact lens
Other names: Avaira Vitality toric lens
contact lens
Other names: Acuvue Oasys for Astigmatism
Time frame: Baseline
Centration of lens on eye (Optimum, Decentration acceptable, Decentration unacceptable)
Time frame: 2 weeks
Centration of lens on eye (Optimum, Decentration acceptable, Decentration unacceptable)
Time frame: Baseline
Lens covering the cornea (Yes, No)
Time frame: 2 weeks
Lens covering the cornea (Yes, No)
Time frame: Baseline
Amount of lens movement after blink (0-5 Likert Scale, 0=Insufficient, 2=Optimal, 4=Excessive movement)
Time frame: 2 weeks
Amount of lens movement after blink (0-5 Likert Scale, 0=Insufficient, 2=Optimal, 4=Excessive movement)
Time frame: 2 weeks
Average daily wearing time (hours/day)
Time frame: 2 weeks
Comfortable daily wearing time (hours/day)
CooperVision, Inc.
Industry
Performance of Toric Silicone Hydrogel Contact Lenses Following Two Weeks of Daily Wear
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06775509
Astigmatism, Eye Diseases
Tarragona, Spain
View Trial DetailsNCT06784063
Astigmatism, Cataract
Bloomfield Hills, Michigan, United States
View Trial DetailsNCT06749496
Astigmatism, Eye Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06967129
Astigmatism, Eye Diseases
Mission Viejo, California, United States
View Trial Details